Vivek  Jain net worth and biography

Vivek Jain Biography and Net Worth

CEO of ICU Medical
Vivek Jain is the chairman and chief executive officer of ICU Medical, a medical device company with more than $315 million in revenues that designs and manufactures some of the world's safest, most reliable devices and systems for infusion therapy, oncology and critical care applications. Since Jain was appointed to this position in February 2014, the ICU Medical share prices have risen approximately 55%.

Prior to joining ICU Medical, Jain served as the president of procedural solutions at CareFusion from 2011 to 2014. In this role, Jain had executive oversight and responsibility for the majority of CareFusion’s medical disposables products, with annual revenues of approximately $1.3 billion. Jain oversaw a diverse range of business units, and during his tenure, each business unit achieved strong growth, broader global reach and improved margins. Prior to this role, Jain served as president of medical technologies and services at CareFusion from 2009 to 2011. Before joining CareFusion, Jain served as executive vice president of strategy and corporate development at Cardinal Health. He was previously the senior vice president of Healthcare Strategy for Philips Medical at Philips Electronics and spent 12 years at J.P. Morgan and its predecessor companies in investment banking.

What is Vivek Jain's net worth?

The estimated net worth of Vivek Jain is at least $18.74 million as of October 1st, 2024. Mr. Jain owns 104,593 shares of ICU Medical stock worth more than $18,743,066 as of October 6th. This net worth evaluation does not reflect any other assets that Mr. Jain may own. Additionally, Mr. Jain receives an annual salary of $1,260,000.00 as CEO at ICU Medical. Learn More about Vivek Jain's net worth.

How old is Vivek Jain?

Mr. Jain is currently 52 years old. There are 3 older executives and no younger executives at ICU Medical. Learn More on Vivek Jain's age.

What is Vivek Jain's salary?

As the CEO of ICU Medical, Inc., Mr. Jain earns $1,260,000.00 per year. Learn More on Vivek Jain's salary.

How do I contact Vivek Jain?

The corporate mailing address for Mr. Jain and other ICU Medical executives is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. ICU Medical can also be reached via phone at (949) 366-2183 and via email at [email protected]. Learn More on Vivek Jain's contact information.

Has Vivek Jain been buying or selling shares of ICU Medical?

Over the course of the past ninety days, Vivek Jain has sold $2,141,520.00 of ICU Medical stock. Most recently, Vivek Jain sold 12,000 shares of the business's stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a transaction totalling $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $18,665,666.78. Learn More on Vivek Jain's trading history.

Who are ICU Medical's active insiders?

ICU Medical's insider roster includes Elisha Finney (Director), Vivek Jain (CEO), George Lopez (Director), Virginia Sanzone (VP), Robert Swinney (Director), Christian Voigtlander (COO), and Daniel Woolson (Corporate Vice President and General Manager, Infusion Systems). Learn More on ICU Medical's active insiders.

Are insiders buying or selling shares of ICU Medical?

In the last year, insiders at the medical instruments supplier sold shares 13 times. They sold a total of 81,382 shares worth more than $10,923,071.66. The most recent insider tranaction occured on October, 1st when CEO Vivek Jain sold 12,000 shares worth more than $2,141,520.00. Insiders at ICU Medical own 6.7% of the company. Learn More about insider trades at ICU Medical.

Information on this page was last updated on 10/1/2024.

Vivek Jain Insider Trading History at ICU Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/1/2024Sell12,000$178.46$2,141,520.00104,593View SEC Filing Icon  
9/3/2024Sell12,000$163.46$1,961,520.00104,593View SEC Filing Icon  
8/16/2024Sell12,000$156.04$1,872,480.00104,593View SEC Filing Icon  
7/12/2023Sell30,000$180.02$5,400,600.0023,677View SEC Filing Icon  
6/14/2023Sell30,000$188.67$5,660,100.0023,677View SEC Filing Icon  
3/3/2022Sell36,000$240.00$8,640,000.00View SEC Filing Icon  
12/30/2021Sell1,159$240.00$278,160.00View SEC Filing Icon  
12/28/2021Sell164$240.00$39,360.00View SEC Filing Icon  
1/8/2021Sell38,591$220.00$8,490,020.0079,607View SEC Filing Icon  
1/6/2021Sell24,339$220.00$5,354,580.0079,607View SEC Filing Icon  
1/4/2021Sell11,500$212.35$2,442,025.0077,741View SEC Filing Icon  
12/4/2020Sell11,500$195.00$2,242,500.0068,541View SEC Filing Icon  
9/1/2020Sell11,500$197.17$2,267,455.0077,681View SEC Filing Icon  
8/27/2020Sell11,500$195.00$2,242,500.0077,681View SEC Filing Icon  
6/1/2020Sell15,000$203.87$3,058,050.0081,211View SEC Filing Icon  
10/20/2017Sell97,795$190.00$18,581,050.0067,680View SEC Filing Icon  
10/10/2017Sell2,205$190.91$420,956.55View SEC Filing Icon  
10/9/2017Sell2,200$190.91$420,002.0044,111View SEC Filing Icon  
7/11/2017Sell100,000$170.80$17,080,000.00110,925View SEC Filing Icon  
7/10/2017Sell3,704$171.00$633,384.00110,925View SEC Filing Icon  
7/7/2017Sell69,014$171.10$11,808,295.40110,925View SEC Filing Icon  
3/10/2017Sell22,143$150.00$3,321,450.0054,554View SEC Filing Icon  
3/6/2017Sell589$150.00$88,350.0064,089View SEC Filing Icon  
8/24/2016Sell7,268$124.25$903,049.0048,497View SEC Filing Icon  
3/5/2014Buy30,000$58.75$1,762,500.0030,000View SEC Filing Icon  
See Full Table

Vivek Jain Buying and Selling Activity at ICU Medical

This chart shows Vivek Jain's buying and selling at ICU Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ICU Medical Company Overview

ICU Medical logo
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Read More

Today's Range

Now: $179.20
Low: $176.87
High: $181.76

50 Day Range

MA: $160.16
Low: $119.68
High: $182.22

2 Week Range

Now: $179.20
Low: $78.28
High: $188.53

Volume

268,478 shs

Average Volume

283,391 shs

Market Capitalization

$4.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.66